Vivere Oncotherapies

Operator of a gene therapy delivery company intended to unlock the full potential of immunotherapy for cold, solid tumors. The company offers best-in-class, IV-administered oncotherapy products developed using its proprietary discovery and powerful protein engineering platforms to create improved delivery vehicles that selectively replicate within tumors, mediate multi-tumor antigen targeting by immune cells, and express multiple cargoes to overcome the immunosuppressive environment of cold tumors, enabling customers to receive effective resolutions for immunologically cold and solid tumors.